Isoflavone supplementation influenced levels of triglyceride and luteunizing hormone in Korean postmenopausal women
- 269 Downloads
- 4 Citations
Abstract
We conducted a double-blind, randomized, placebo-controlled trial to evaluate the effects of soy-derived isoflavone on blood glucose, lipid profiles, and sex hormones related to cardiovascular disease in Korean postmenopausal women. One hundred thirteen postmenopausal women were recruited from the Seoul metropolitan area. To confirm postmenopausal and gynecologic status, the subjects were clinically examined by a gynecologist using ultra sound and X-ray. Finally, 85 postmenopausal women whose follicle-stimulating hormone (FSH) levels were higher than 40 IU/ml were enrolled. Subjects received either 70 mg isoflavone or placebo capsules daily for 12 weeks. As a result, the values of fasting glucose, insulin and HOMA-IR, as well as those of TC, LDL-C, HDL-C and FFA, were not different between the groups after supplementation. However, triglyceride (TG) levels in the treatment group decreased significantly compared with those of the placebo group (p = 0.0215). The levels of luteinizing hormone (LH) significantly decreased in the treatment group (p = 0.027); however, the levels of FSH, estrone and estradiol were not changed after intervention. In conclusion, isoflavone supplement of 70 mg/day for 12 weeks decreased blood levels of TG and LH in Korean postmenopausal women.
Keywords
Postmenopausal women Isoflavone Lipid profiles Sex hormones KoreanNotes
Acknowledgments
This work was supported by “Food Functionality Evaluation Program” under the Ministry of Food, Agriculture, Forestry and Fisheries in part.
References
- Choi, I.S., Y.J. Bae, S. Jang, D.H. Lee, M.E. Yun, H.S. Lee, M.H. Kim, S.H. Lee, and C.J. Sung. 2005. Effect of soy isoflavone supplementation and exercise on serum lipids in postmenopausal women. Korean Journal of Nutrition 38: 411–418.Google Scholar
- Duncan, A.M., K.E. Underhill, X. Xu, J. Lavalleur, W.R. Phipps, and M.S. Kurzer. 1999. Modest hormonal effects of soy isoflvones in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 84: 3479–3484.PubMedCrossRefGoogle Scholar
- Ferrara, C.M., N.A. Lynch, B.J. Nicklas, A.S. Ryan, and D.M. Berman. 2002. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. Journal of Clinical Endocrinology and Metabolism 87: 4166–4170.PubMedCrossRefGoogle Scholar
- Franke, A.A., J.H. Hankin, M.C. Yu, G. Maskarinec, S.H. Low, and L.J. Custer. 1999. Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. Journal of Agriculture and Food Chemistry 47: 977–986.CrossRefGoogle Scholar
- Glazier, M.G., and M.A. Bowman. 2001. A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Archives of Internal Medicine 161: 1161–1172.PubMedCrossRefGoogle Scholar
- Goodman-Gruen, D., and D. Kritz-Silverstein. 2001. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. Journal of Nutrition 131: 1202–1206.PubMedGoogle Scholar
- Han, K.K., J.M. Soares, M.A. Haidar, G.R. de Lima, and E.C. Baracat. 2002. Benefits of soy isoflavone therapeutic regime on menopausal symptoms. Obstetrics & Gynecology 99: 389–394.CrossRefGoogle Scholar
- Ho, S.C., A.S. Chan, Y.P. Ho, E.K. So, A. Sham, B. Zee, J.L. Woo. 2007. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause 14: 489–499.Google Scholar
- Lee, S.K., M.J. Lee, S. Yoon, and D.J. Kwon. 2000. Estimated isoflavone intake from soy products in Korean middle-aged women. Journal of the Korean Society of Food Science and Nutrition 29: 948–956.Google Scholar
- Maskarinec, G., S. Singh, L. Meng, and A.A. Franke. 1998. Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiology. Biomarkers & Prevention 7: 613–619.Google Scholar
- Matthews, K.A., L.H. Kuller, K. Sutton-Tyrrell, and Y.F. Chang. 2001. Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 32: 1104–1111.PubMedCrossRefGoogle Scholar
- Park, H.A., J.K. Park, S.A. Park, and J.S. Lee. 2010. Age, menopause, and cardiovascular risk factors among Korean middle-aged women: the 2005 Korea National Health and Nutrition Examination Survey. Journal of Womens Health 19: 869–876.CrossRefGoogle Scholar
- Petri, N.E., N.J. Nahás, L. De Luca, P. Traiman, A. Pontes, and I. Dalben. 2004. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 48: 372–380.CrossRefGoogle Scholar
- Rosano, G.M., C. Vitale, G. Marazzi, and M. Volterrani. 2007. Menopause and cardiovascular disease: the evidence. Climacteric 10: 19–24.PubMedCrossRefGoogle Scholar
- Sacks, F.M., A. Lichtenstein, H.L. Van, W. Harris, P. Kris-Etherton, and M. Winston. 2006. Soy Protein, Isoflavones, and cardiovascular health. An American Heart Association Science Advisory for Professionals from the Nutrition Committee. Circulation 113: 1034–1044.PubMedCrossRefGoogle Scholar
- Scambia, G., D. Mango, P.G. Signorile, R.A. Angeli, C. Palena, D. Gallo, E. Bombardelli, P. Morazzoni, A. Riva, and S. Mancuso. 2000. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 7: 105–111.PubMedCrossRefGoogle Scholar
- Stampfer, M.J., G.A. Colditz, W.C. Willett, J.E. Manson, B. Rosner, F.E. Speizer, and C.H. Hennekens. 1991. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses’ Health Study. New England Journal of Medicine 325: 756–762.PubMedCrossRefGoogle Scholar
- The Women’s Health Initiative Steering Committee. 2004. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. JAMA 291: 1701–1712.CrossRefGoogle Scholar
- Usui, T. 2006. Pharmaceutical prospects of phytoestrogens. Endocrine Journal 53: 7–20.PubMedCrossRefGoogle Scholar
- Vitale, C., M. Fini, G. Speziale, and S. Chierchia. 2010. Gender differences in the cardiovascular effects of sex hormones. Fundamental & Clinical Pharmacology 24: 675–685.CrossRefGoogle Scholar
- WHI and WHI-CACS Investigators. 2007. Estrogen therapy and coronary-artery calcification. The New England Journal of Medicine 356: 2591–2602.CrossRefGoogle Scholar
- Writing Group for the Women’s Health Initiative Investigators. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288: 321–333.CrossRefGoogle Scholar
- Ye, Y.B., Z.L. Wang, S.Y. Zhuo, W.M. Lu, H.F. Liao, M.A. Verbruggen, S. Fang, H.Y. Mai, Y.M. Chen, and Y.X. Su. 2012. Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomized placebo-controlled trial. Menopause 19: 791–798.Google Scholar
- Zhan, S., and S.C. Ho. 2005. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. American Journal of Clinical Nutrition 81: 397–408.PubMedGoogle Scholar